New pill combo targets tough cancers in early trial
NCT ID NCT03968653
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 35 times
Summary
This early-phase study tested an oral drug called Debio 0123 combined with the chemotherapy carboplatin in 76 adults with advanced solid tumors that had come back or worsened after prior platinum-based treatment. The main goals were to find the safest dose and check for side effects. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinica Universidad de Navarra
Madrid, 28027, Spain
-
Clinica Universidad de Navarra - Pamplona
Pamplona, 31008, Spain
-
Hospital Universitario Virgen de la Victoria
Málaga, 29010, Spain
-
Hospital Vall Hebrón, Unidad de Investigación en Terapia Molecular (UITM)
Barcelona, 08035, Spain
-
Instituto Valenciano de Oncologia
Valencia, 46009, Spain
-
Leiden University Medical Center, Dept. of Clinical Oncology
Leiden, 2333, Netherlands
-
Radboud university medical center
Nijmegen, 6525, Netherlands
-
University Medical Center Groningen
Groningen, 9713, Netherlands
Conditions
Explore the condition pages connected to this study.